Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.
Pennington MW, Beeton C, Galea CA, Smith BJ, Chi V, Monaghan KP, Garcia A, Rangaraju S, Giuffrida A, Plank D, Crossley G, Nugent D, Khaytin I, Lefievre Y, Peshenko I, Dixon C, Chauhan S, Orzel A, Inoue T, Hu X, Moore RV, Norton RS, Chandy KG.
Mol Pharmacol. 2009 Apr;75(4):762-73. Epub 2009 Jan 2.PMID: 19122005 [PubMed - indexed for MEDLINE]Related articles